cdk6 can shorten G(1) phase dependent upon the N-terminal INK4 interaction domain (Q28145650)

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

D-type cyclin-dependent kinase activity in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

Identification of G1 kinase activity for cdk6, a novel cyclin D partner

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

The retinoblastoma protein and cell cycle control

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

Principles of CDK regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

WAF1, a potential mediator of p53 tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

p21 is a universal inhibitor of cyclin kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

p21-containing cyclin kinases exist in both active and inactive states

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

New functional activities for the p21 family of CDK inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

A novel cyclin encoded by a bcl1-linked candidate oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

A cell cycle regulator potentially involved in genesis of many tumor types

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

MDM2 and CDK4 gene amplification in Ewing's sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

Inhibition of p53-mediated growth arrest by overexpression of cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

Distinct roles for cyclin-dependent kinases in cell cycle control

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

Suppression of human colorectal carcinoma cell growth by wild-type p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

High-efficiency transformation of mammalian cells by plasmid DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

Requirement of cyclin E-Cdk2 inhibition in p16(INK4a)-mediated growth suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

Active cdk6 complexes are predominantly nuclear and represent only a minority of the cdk6 in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

Modeling mutations in the G1 arrest pathway in human gliomas: overexpression of CDK4 but not loss of INK4a-ARF induces hyperploidy in cultured mouse astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

Induced expression of p16(INK4a) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960

Interaction between Cdc37 and Cdk4 in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.29960